Patent intelligence · US
US 2023040008
ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES
ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES
Patent details — US 2023040008
- Jurisdiction
- US
- Status
- granted
- Grant date
- Feb 9, 2023
- Expiration
- Feb 4, 2043
- Applicant
- BRACCO IMAGING SPA [IT]
- CPC classes
- A61K 49/ 00 A I, A61K/490032, A61K/490056
Quick answer
US 2023040008 (ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES) is held by BRACCO IMAGING SPA [IT]. Status: granted. Granted Feb 9, 2023. Expires Feb 4, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BRACCO IMAGING SPA [IT]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 49/ 00 A I, A61K/490032, A61K/490056
More from BRACCO IMAGING SPA [IT]
Related pharmaceutical patents in our USPTO index.
-
CN 119365549
Fluorescent probe targeting CA-IX
granted -
CN 119343336
1, 4-bis-(2-hydroxy-benzyl)-1, 4, 7-triazacyclononane derivatives and similar compounds as ligands in iron (iii) complexes for use as MRI contrast agents
granted -
CN 119325492
Fluorescent probe targeting CA-IX
granted -
CN 118401500
Process for preparing mixtures of dimeric macrocyclic intermediates comprising gadolinium complexes
granted -
US 2024131199
PH RESPONSIVE CYANINE DYES AND CONJUGATES THEREOF
granted -
KR 20240034693
이량체 조영제의 제조
granted -
US 2023312523
NEAR-INFRARED CYANINE DYES AND CONJUGATES THEREOF
granted -
KR 20230116805
가도테리돌 제조를 위한 제조 방법
granted
Frequently asked questions
What is US patent 2023040008?
US 2023040008 (ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES) is held by BRACCO IMAGING SPA [IT]. Status: granted. Granted Feb 9, 2023. Expires Feb 4, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 2023040008?
BRACCO IMAGING SPA [IT] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does US 2023040008 expire?
Our index shows an expiration date of Feb 4, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.